These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6312756)

  • 21. Enhancement of antitumor activity of alkylating agents by the radiation sensitizer misonidazole.
    Clement JJ; Gorman MS; Wodinsky I; Catane R; Johnson RK
    Cancer Res; 1980 Nov; 40(11):4165-72. PubMed ID: 7471058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Misonidazole combined with radiotherapy in the treatment of inoperable squamous cell carcinoma of the lung. A double-blind randomized trial.
    Panduro J; Kjaer M; Wolff-Jensen J; Hansen HH
    Cancer; 1983 Jul; 52(1):20-4. PubMed ID: 6303553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bladder cancer. The selection of patients for treatment by full-dose irradiation.
    Shipley WU; Rose MA
    Cancer; 1985 May; 55(9 Suppl):2278-84. PubMed ID: 3919933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxic-cell sensitisers.
    Karim AB
    Lancet; 1978 Oct; 2(8095):891-2. PubMed ID: 81431
    [No Abstract]   [Full Text] [Related]  

  • 25. Radical radiation and oral and intra-vesical misonidazole for bladder cancer.
    Abratt RP; Barnes DR; Pontin AR; Sarembock LA; Williams AM
    Int J Radiat Oncol Biol Phys; 1987 Jul; 13(7):1053-5. PubMed ID: 3597148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Local administration of radiosensitizer misonidazole].
    Otsuka S; Suda K; Yamashita J; Gi H; Oda Y; Takeuchi J; Handa H; Ono K
    No To Shinkei; 1983 Mar; 35(3):249-55. PubMed ID: 6687999
    [No Abstract]   [Full Text] [Related]  

  • 27. Combination of misonidazole and m-AMSA: effects on radiation sensitivity and toxicity in E. coli.
    Roberts PB
    Int J Radiat Biol Relat Stud Phys Chem Med; 1982 Aug; 42(2):173-83. PubMed ID: 6752069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary results of RTOG phase I/II study of misonidazole and radiation for bladder cancer.
    Mohiuddin M; Kramer S; Phillips T; Soberon M; Forgione H
    Am J Clin Oncol; 1982 Oct; 5(5):551-4. PubMed ID: 7180834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
    McNally NJ; Hinchliffe M; de Ronde J
    Br J Cancer; 1983 Aug; 48(2):271-8. PubMed ID: 6882665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical studies of combined therapy of radiation and local injection of misonidazole].
    Hong SS; Abe Y; Isobe Y; Yamakawa M; Kaneta K; Kawaguchi T; Matsuzawa T; Umegaki Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 May; 43(5):675-84. PubMed ID: 6622246
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experience with daily doses of misonidazole (author's transl)].
    Kogelnik HD; Reinartz G; Szepesi T; Seitz W; Wurst F; Mamoli B; Wessely P; Stark H
    Strahlentherapie; 1980 Nov; 156(11):758-64. PubMed ID: 7434385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of misonidazole on the radiosensitivity of transplantable transitional cell bladder carcinoma in mice.
    Hampel N; Persky L
    Invest Urol; 1981 Jul; 19(1):14-6. PubMed ID: 7251317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of combined misonidazole and accelerated neon ions on a human melanoma transplanted into nude mice.
    Guichard M; Tenforde T; Curtis S; Malaise EP
    Radiology; 1982 Jan; 142(1):219-23. PubMed ID: 6796997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of combined misonidazole and d(50)-Be neutrons on a human melanoma transplanted into nude mice.
    Guichard M; Gueulette J; Octave-Prignot M; Wambersie A; Malaise EP
    Radiology; 1980 Aug; 136(2):479-84. PubMed ID: 7403527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide.
    Hoskin PJ; Saunders MI; Dische S
    Cancer; 1999 Oct; 86(7):1322-8. PubMed ID: 10506720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of radioresponse of a mouse mammary carcinoma to combined treatments with hyperthermia and radiosensitizer misonidazole.
    Goldfeder A; Brown DM; Berger A
    Cancer Res; 1979 Aug; 39(8):2966-70. PubMed ID: 455281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Misonidazole-a drug for trial in radiotherapy and oncology.
    Dische S; Saunders MI; Flockhart IR; Lee ME; Anderson P
    Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):851-60. PubMed ID: 227822
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics of the hypoxic radiosensitizers misonidazole and demethylmisonidazole after intraperitoneal administration in humans.
    Gianni L; Jenkins JF; Greene RF; Lichter AS; Myers CE; Collins JM
    Cancer Res; 1983 Feb; 43(2):913-6. PubMed ID: 6848201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of even or uneven dose fractionation regime on murine squamous cell carcinoma with combined use of misonidazole].
    Yasunaga T; Takada C; Takahashi M; Okada S; Sakamoto K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Oct; 43(10):1224-31. PubMed ID: 6672751
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical experiences with the radiation-sensitizing agent misonidazole].
    Kogelnik HD; Szepesi T; Kärcher KH; Seitz W
    Strahlentherapie Sonderb; 1978; 75():115-9. PubMed ID: 162327
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.